Dyne Therapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
DYN Company Description
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.
DYN Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view DYN Smart Score
Score Breakdown
DYN Company Description
Show More
Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of DYN by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by DYN's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on DYN's company Twitter account
WallStreetBets
Number of mentions of DYN in WallStreetBets Daily Discussion
DYN News
Recent insights relating to DYN
CNBC Recommendations
Recent picks made for DYN stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in DYN
Corporate Flights
Flights by private jets registered to DYN
Our Analysis